Vascular and cardiac function in young adults with classical congenital adrenal hyperplasia

Joanna Wierzbicka-Chmiel1, Artur Chmiel, Sławomir Rychlik

  • 1Department of Endocrinology, Hospital Rybnik, Poland. jwierzbickachmiel@wp.pl.

Endokrynologia Polska
|September 8, 2017
PubMed

Insights

Young adults with congenital adrenal hyperplasia (CAH) on long-term glucocorticoid therapy show impaired vascular function and subclinical cardiac changes. This study highlights potential cardiovascular risks in CAH patients despite treatment.

Area of Science:

  • Cardiology
  • Endocrinology
  • Vascular Biology

Background:

  • Patients with classical congenital adrenal hyperplasia (CAH) face elevated cardiovascular risks.
  • The long-term effects of corticoid replacement therapy on vascular and cardiac function in CAH are not fully understood.

Purpose of the Study:

  • To evaluate vascular and cardiac function in adult patients with CAH undergoing long-term glucocorticoid replacement therapy.
  • To compare vascular parameters and cardiac function between CAH patients and healthy controls.

Main Methods:

  • A cross-sectional study involving 19 Caucasian adults with CAH and 20 matched healthy volunteers.
  • Assessment included flow-mediated dilation (FMD) of the brachial artery, intima-media thickness (cIMT, fIMT) of carotid and femoral arteries, standard echocardiography, and 2D speckle-tracking echocardiography (LSTE) for global longitudinal strain.

Main Results:

  • CAH patients exhibited significantly decreased FMD compared to controls (9.4% vs. 19.8%).
  • Intima-media thickness (cIMT and fIMT) was initially higher in CAH patients but not after confounder correction.
  • Left ventricular ejection fraction and mass index were similar; however, LSTE revealed subclinical differences in global longitudinal strain (-20.5% vs. -22.5%).

Conclusions:

  • Long-lasting glucocorticoid treatment in young adults with CAH is associated with impaired FMD.
  • While IMT showed an insignificant increase, subclinical changes in left ventricular diastolic function were detected via echocardiography.
Abstract

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
3.4K
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
5.7K
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
4.7K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.7K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
633
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
553